Clinical Trial: Becotatug Vedotin combined with Palbociclib for advanced head and neck squamous cell carcinoma after failure of first-line treatment (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Becotatug Vedotin combined with Palbociclib for advanced head and neck squamous cell carcinoma after failure of first-line treatment'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129847

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=325479

Published by HT Digital Content Services with permission from Health Daily Digest....